Hong Kong Stock Movement | CARsgen Therapeutics-B (02171.HK) rose nearly 3% before noon; FNC lymphodepletion pretreatment regimen receives formal patent authorization in China.
Zhito Finance APP has learned that CARsgen Therapeutics-B (02171.HK) rose nearly 3% before noon, up 2.47% as of press time, at HK$12.86, with a turnover of HK$16.4403 million.
Latest
